Identifying and improving unreliable items in registries through data auditing

International Journal for Quality in Health Care

Volumn 23, Issue 3, 2011, Pages 317-323

  Willis, Cameron D ^a   Jolley, Damien J ^b   Mcneil, John J ^b   Cameron, Peter A ^b,c   Phillips, Louise E ^b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c ALFRED HOSPITAL   (Australia)

Author keywords

Data quality; Recombinant FVIIa; Registries

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ARTICLE; AUSTRALIA; BLEEDING; HEALTH CARE QUALITY; HUMAN; MEDICAL AUDIT; NEW ZEALAND; PRIORITY JOURNAL; REGISTER;

AUSTRALIA; CLINICAL AUDIT; FACTOR VIIA; HEMOSTATICS; HUMANS; NEW ZEALAND; OFF-LABEL USE; QUALITY CONTROL; RECOMBINANT PROTEINS; REGISTRIES; REPRODUCIBILITY OF RESULTS; SINGLE-BLIND METHOD;

EID: 79955994776     PISSN: 13534505     EISSN: 14643677     Source Type: Journal    
DOI: 10.1093/intqhc/mzr004     Document Type: Article

References (31)

1. Australian Commission on Safety and Quality in Healthcare. Operating Principles and Technical Standards for Australian Clinical Quality Registries. Canberra: Australian Commission on Safety and Quality in Healthcare, 2008.
2. Graves S, Davidson D, Ingerson L et al. The Australian Orthopaedic Association National Joint Replacement Registry. Med J Aust 2004;180:S31-4.
3. Owen A, Spinks J, Meehan A et al. A new model to evaluate the long-term cost effectiveness of orphan and highly specialised drugs following listing on the Australian Pharmaceutical Benefits Scheme: the Bosentan Patient Registry. J Med Econ 2008;11:235-43.
4. Larsen I, Smstuen M, Johannesen T et al. Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness. Eur J Cancer 2009;45:1218-31.
5. Malin J, Kahn K, Adams J et al. Validity of cancer registry data for measuring the quality of breast cancer care. J Natl Cancer Inst 2002;94:835-44.
6. Cameron PA, Finch CF, Gabbe BJ et al. Developing Australia's first statewide trauma registry: what are the lessons? ANZ J Surg 2004;74:424-8.
7. Arts DGT, De Keizer N, Scheffer G-J. Defining and improving data quality in medical registries: a literature review, case study, and generic framework. J Am Med Inform Assoc 2002;9:600-11.
8. National Health Service. DocDat Data Collection Manual. The Information Centre for Health and Social Care, London: NHS, 2007.
9. Bray F, Parkin DM. Evaluation of data quality in the cancer registry: principles and methods. Part I: comparability, validity and timeliness. Eur J Cancer 2009;45:747-55.
10. van der Meulen JHP, Jacob M, Copley L. Assessing the quality of the data in a transplant registry: the European Liver Transplant Registry. Transplantation 2003;75:2164-7.
11. Olsson C, Eriksson N, Sthle E et al. The Swedish Heart Surgery Register: data quality for proximal thoracic aortic operations. Scand Cardiovasc J 2006;40:348-53.
12. Hoffman M, Monroe DM. A cell-based model of hemostasis. Thromb Haemost 2001;85:958-65.
13. Lloyd Jones M, Wight J, Paisley S et al. Control of bleeding in patients with haemophilia A with inhibitors: a systematic review. Haemophilia 2003;9:464-520.
14. Key NS, Aledort LM, Beardsley D et al. Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors. Thromb Haemost 1998;80:912-8.
15. Karkouti K, Beattie WS, Arellano R et al. Comprehensive Canadian review of the off-label use of recombinant activated factor VII in cardiac surgery. Circulation 2008;118:331-8.
16. Kenet G, Walden R, Eldad A et al. Treatment of traumatic bleeding with recombinant factor VIIa. Lancet 1999;354:1879.
17. Dunkley S, Phillips L, McCall P et al. Recombinant activated factor VII in cardiac surgery: experience from the Australian and New Zealand Haemostasis Registry. Ann Thorac Surg 2008;85:836-44.
18. Karam V, Gunson B, Roggen F et al. Quality control of the European Liver Transplant Registry: results of audit visits to the contributing centers. Transplantation 2003;75:2167-73.
19. Isbister J, Phillips L, Dunkley S et al. Recombinant activated factor VII in critical bleeding: experience from the Australian and New Zealand Haemostasis Register. Intern Med J 2008;38:156-65.
20. Rock G, Berger R, Filion D et al. Documenting a transfusion: how well is it done? Transfusion 2007;47:568-72.
21. Whitney CW, Lind BK, Wahl PW. Quality assurance and quality control in longitudinal studies. Epidemiol Rev 1998;20:71-80.
22. Reeves MJ, Mullard AJ, Wehner S. Inter-rater reliability of data elements from a prototype of the Paul Coverdell National Acute Stroke Registry. BMC Neurol 2008;8:19-27.
23. Yoon S, George M, Myers S et al. Analysis of data-collection methods for an acute stroke care registry. Am J Prev Med 2006;31:S196-201.
24. Donders ART, van der Heijden GJ, Stijnen T et al. Review: a gentle introduction to imputation of missing values. J Clin Epidemiol 2006;59:1087-91.
25. Donner A, Eliasziw M. A goodness-of-fit approach to inference procedures for the kappa statistic: confidence interval construction, significance-testing and sample size estimation. Stat Med 1992;11:1511-9.
26. Machin D, Campbell MJ, Tan SB et al. Sample Size Tables for Clinical Studies. Chichester: Wiley-Blackwell, 2009, 179-94.
27. Walter SD, Eliasziw M, Donner A. Sample size and optimal designs for reliability studies. Stat Med 1998;17:101-10.
28. Eliasziw M, Donner A. A cost-function approach to the design of reliability studies. Stat Med 1987;6:647-55.
29. Shoukri MM, Asyali MH, Walter SD. Issues of cost and efficiency in the design of reliability studies. Biometrics 2003;59:1107-12.
30. Feinstein AR, Cicchetti DV. High agreement but low kappa: I. The problems of two paradoxes. J Clin Epidemiol 1990;43:534-49.
31. McNeil J, Evans S, Crammond B et al. Guidelines for the Establishment and Management of Clinical Registries. Melbourne: Prepared on Behalf of the Australian Commission on Safety and Quality in Health Care, 2008.